Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 209-216

  Le Bail, J C ^a   Varnat, F ^a   Nicolas, J C ^b   Habrioux, G ^a  

^a UPRES EA 1085   (France)

^b INSERM   (France)

Author keywords

Estrogen receptor; Flavonoids; Luciferase activity; MCF 7 cells

Indexed keywords

APIGENIN; CHRYSIN; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONOID; GENISTEIN; HYDROXYL GROUP; ISOQUERCITRIN; KAEMPFEROL; LUCIFERASE; LUTEOLIN; NARINGENIN; QUERCETIN; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; ESTROGEN ANTAGONISTS; FEMALE; FLAVONOIDS; FLAVONOLS; GENES, REPORTER; GENISTEIN; HUMANS; LUCIFERASES; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032516686     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00141-4     Document Type: Article

References (26)

1. Adlercreutz H., Mousavi Y., Höckerstedt K. Diet and breast cancer. Acta Oncol. 31:1992;175-181.
2. Adlercreutz H., Bannwart C., Wähälä K., Mäkelä T., Brunow G., Hase T., Arosemena P.J., Kellis J.T., Vickery L.E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol. 44:1993;147-153.
3. Bradford M. A rapid and sensitive method for the quantification of microgramme quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
4. Cassady J.M., Zennie T.M., Chae Y.H., Ferrin M.A., Portundo N.E., Baired W.M. Use of a mammalian cell culture benzo(α)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res. 48:1988;6257-6261.
5. Collins M.B., McLachlan J.A., Arnold S.F. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids. 62:1997;365-372.
6. Dowsett M., Macaulay V., Oledhill J., Ryde C., Nicholls J., Asworth A., Kinna M.C., Smith I.E. Control of aromatase in breast cancer cells and its importance for tumor growth. J. Steroid Biochem. Mol. Biol. 44:1993;605-609.
7. Faye J.C., Fargin A., Vallette A., Bayard F. Antiestrogens, different sites of action than the estrogen receptor. Hormone Res. 28:1987;202-211.
8. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA. 90:1993;2690-2694.
9. Gaudette D.C., Holub B.J. Effect of genistein, a tyrosine kinase inhibitor, on U46619-induced phosphoinoside phosphorylation in human platelets. Biochem. Biophys. Res. Commun. 170:1990;238-242.
10. Kellis J.T., Vickery L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 225:1984;1032-1034.
11. Ibrahim A.R., Abul-Hajj Y. Aromatase inhibition by flavonoids. J. Steroid Biochem. Mol. Biol. 37:1990;257-260.
12. Ito M., Ishimoto S., Nishida Y., Shiramizu T., Yumoki H. Effects of baicalein, a flavonoid, and other anti-inflammatory agents on glyoxalase-I activity. Agric. Biol. Chem. 50:1986;1073-1074.
13. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects on breast cancer risk in Singapore. Lancet. 337:1991;1197-1200.
14. MacIndoe J.H., Etre L.A. Androgens inhibit estrogen action in MCF-7 human breast cancer cells. Life Sci. 27:1980;1643-1648.
15. Makela S., Davis V.L., Tally W.C., Korkman J., Salo L., Vihko R., Santti R., Korach K.S. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 102:1994;572-578.
16. Markiewitcz L., Garey J., Adlercreutz H., Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45:1993;399-405.
17. Martin P.M., Horowitz K.B., Ryan D.S., McGuire W.L. Phytoestrogen interaction with estrogen receptor in human breast cancer cells. Endocrinology. 103:1978;1860-1867.
18. Miksicek R.J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49:1994;153-160.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
20. Perel E., Daniilescu D., Kharpil L., Blaschstain M., Killinger D.W. Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J. Steroid Biochem. 29:1988;393-399.
21. Pons M., Gagne D., Nicolas J.C., Mehtali N. A new cellular model of response to estrogens. Biotechniques. 9:1990;450-459.
22. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., Safe S. Naringenin: a weakly estrogenic bioflavonoids that exhibits antiestrogenic activity. Biochem. Pharmacol. 50:1995;1485-1493.
23. So V.F., Guthrie N., Chambers A.F., Moussa M., Carroll K.K. Inhibition of breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer. 26:1996;167-181.
24. Vrijsen R., Everaert L., Boeye A. Antiviral activity of flavones and potentiation by ascorbate. J. Gen. Virol. 69:1988;1749-1751.
25. Wang T.T.Y., Sathyamoorthy N., Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 17:1996;271-275.
26. Yanagihara K., Ito A., Toge T., Numoto M. Antiproliferative effect of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:1993;5815-5821.